By lowering the inflammation burden, the MD may help improve tolerability and enhance semaglutides efficacy in improving glycaemic and metabolic outcomes, especially in patients with high inflammatory burden, metabolic syndrome, or comorbid inflammatory conditions [125, 126]
During Ozempic treatment, understanding how coffee consumption may impact the medications absorption, effectiveness, and blood sugar regulation is important
Administration of a GLP-1 RA may decrease glucagon secretion and hepatic gluconeogenesis
Of those using 10 mg tirzepatide, 65% had a weight regain of less than 5%, 26% regained between 5% and 10% of their weight and 9% regained 10% or more of their body weight
GLP-1 agonists work by mimicking a hormone to lower blood sugar levels and inhibit appetite